000			02017 a2200553 4500
005			20250516225555.0
264		0	_c20151208
008			201512s 0 0 eng d
022			_a1528-3658
024	7		_a10.2119/molmed.2014.00059 _2doi
040			_aNLM _beng _cNLM
100	1		_aMa, Shao-lin
245	0	0	_aLapatinib antagonizes multidrug resistance-associated protein 1-mediated multidrug resistance by inhibiting its transport function. _h[electronic resource]
260			_bMolecular medicine (Cambridge, Mass.) _cSep 2014
300			_a390-9 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAnimals
650	0	4	_aAntineoplastic Agents _xpharmacology
650	0	4	_aBiological Transport _xdrug effects
650	0	4	_aCell Line, Tumor
650	0	4	_aCell Survival _xdrug effects
650	0	4	_aCisplatin _xpharmacology
650	0	4	_aDoxorubicin _xpharmacology
650	0	4	_aDrug Resistance, Multiple _xdrug effects
650	0	4	_aDrug Resistance, Neoplasm _xdrug effects
650	0	4	_aDrug Synergism
650	0	4	_aExtracellular Signal-Regulated MAP Kinases _xmetabolism
650	0	4	_aHEK293 Cells
650	0	4	_aHumans
650	0	4	_aLapatinib
650	0	4	_aMice
650	0	4	_aMice, Nude
650	0	4	_aMultidrug Resistance-Associated Protein 2
650	0	4	_aMultidrug Resistance-Associated Proteins _xantagonists & inhibitors
650	0	4	_aNIH 3T3 Cells
650	0	4	_aNeoplasms _xdrug therapy
650	0	4	_aProto-Oncogene Proteins c-akt _xmetabolism
650	0	4	_aQuinazolines _xpharmacology
650	0	4	_aTumor Burden _xdrug effects
650	0	4	_aVincristine _xpharmacology
700	1		_aHu, Ya-peng
700	1		_aWang, Fang
700	1		_aHuang, Zhen-cong
700	1		_aChen, Yi-fan
700	1		_aWang, Xiao-kun
700	1		_aFu, Li-wu
773	0		_tMolecular medicine (Cambridge, Mass.) _gvol. 20 _gp. 390-9
856	4	0	_uhttps://doi.org/10.2119/molmed.2014.00059 _zAvailable from publisher's website
999			_c24081740 _d24081740